Login

Creating, facilitating, and promoting sustainable Health Technology Assessment (HTA) cooperation in Europe

PTRCR18 – Dexamethasone for the treatment of hospitalised patients with COVID-19 – Final Rapid Collaborative Review now available.

By admin  / November 19, 2020
PTRCR18 – Dexamethasone for the treatment of hospitalised patients with COVID-19 – Final Rapid Collaborative Review now available.

Patient group input requested for a new Joint Assessment on a medicinal product for cerebral adrenoleukodystrophy (CALD).

By admin  / November 6, 2020
Patient group input requested for a new Joint Assessment on a medicinal product for cerebral adrenoleukodystrophy (CALD).

PTRCR15 – Remdesivir for the treatment of COVID-19. PICO and Evidence gaps – Final Rapid Collaborative Review now available

By admin  / September 30, 2020
PTRCR15 – Remdesivir for the treatment of COVID-19. PICO and Evidence gaps – Final Rapid Collaborative Review now available

Patient group input requested for a new Joint Assessment on a medicinal product for acute myeloid leukaemia (AML).

By admin  / September 21, 2020

PTJA14 – Pretomanid in combination with bedaquiline and linezolid in adults for the treatment of pulmonary extensively drug-resistant (XDR), or treatment-intolerant or nonresponsive multidrug-resistant (MDR) tuberculosis (TB) – Final assessment now available

By admin  / August 19, 2020

Custom icon
Early Dialogues

Custom icon
Submission & Methodology

Custom icon
Assessments

Custom icon
National Implementation

Services

Assessments

Tools

Have Questions? Check our FAQ